Chinese Clinical Trial Register (ChiCTR) - The world health organization international clinical trials registered organization registered platform

简体中文|English

Trial search

Nation, Province(City)

Measure

Ethical committee

Study type

According to the province of each country (municipality directly under the Central Government) statistics

Year：

Shanghai

Code of disease Primary sponsor(s) Secondary sponsor(s) Funding source Check the details 7(15.91%)

Sichuan

Code of disease Primary sponsor(s) Secondary sponsor(s) Funding source Check the details 3(6.82%)

Beijing

Code of disease Primary sponsor(s) Secondary sponsor(s) Funding source Check the details 3(6.82%)

Liaoning Province

Code of disease Primary sponsor(s) Secondary sponsor(s) Funding source Check the details 2(4.55%)

Guangdong

Code of disease Primary sponsor(s) Secondary sponsor(s) Funding source Check the details 2(4.55%)

Chongqing

Code of disease Primary sponsor(s) Secondary sponsor(s) Funding source Check the details 2(4.55%)

Anhui Province

Code of disease Primary sponsor(s) Secondary sponsor(s) Funding source Check the details 2(4.55%)

Zhejiang

Code of disease Primary sponsor(s) Secondary sponsor(s) Funding source Check the details 2(4.55%)

Jiangsu

Code of disease Primary sponsor(s) Secondary sponsor(s) Funding source Check the details 2(4.55%)

Tibet Autonomous Region

Code of disease Primary sponsor(s) Secondary sponsor(s) Funding source Check the details 1(2.27%)

Tianjin

Code of disease Primary sponsor(s) Secondary sponsor(s) Funding source Check the details 1(2.27%)

Guangdong Province

Code of disease Primary sponsor(s) Secondary sponsor(s) Funding source Check the details 1(2.27%)

Jiangsu Province

Code of disease Primary sponsor(s) Secondary sponsor(s) Funding source Check the details 1(2.27%)

Henan

Code of disease Primary sponsor(s) Secondary sponsor(s) Funding source Check the details 1(2.27%)

Inner Mongolia Autonomous Region

Code of disease Primary sponsor(s) Secondary sponsor(s) Funding source Check the details 1(2.27%)

Jiangxi Province

Code of disease Primary sponsor(s) Secondary sponsor(s) Funding source Check the details 1(2.27%)

Hunan

Code of disease Primary sponsor(s) Secondary sponsor(s) Funding source Check the details 1(2.27%)

Hubei

Code of disease Primary sponsor(s) Secondary sponsor(s) Funding source Check the details 1(2.27%)

Shandong

Code of disease Primary sponsor(s) Secondary sponsor(s) Funding source Check the details 1(2.27%)

Liaoning

Code of disease Primary sponsor(s) Secondary sponsor(s) Funding source Check the details 1(2.27%)

Gansu

Code of disease Primary sponsor(s) Secondary sponsor(s) Funding source Check the details 1(2.27%)

Inner Mongolia

Code of disease Primary sponsor(s) Secondary sponsor(s) Funding source Check the details 1(2.27%)

Yunnan

Code of disease Primary sponsor(s) Secondary sponsor(s) Funding source Check the details 1(2.27%)

Hebei

Code of disease Primary sponsor(s) Secondary sponsor(s) Funding source Check the details 1(2.27%)

Guangxi

Code of disease Primary sponsor(s) Secondary sponsor(s) Funding source Check the details 1(2.27%)

Guizhou

Code of disease Primary sponsor(s) Secondary sponsor(s) Funding source Check the details 1(2.27%)

Qinghai

Code of disease Primary sponsor(s) Secondary sponsor(s) Funding source Check the details 1(2.27%)

Heilongjiang

Code of disease Primary sponsor(s) Secondary sponsor(s) Funding source Check the details 1(2.27%)

Chinese Clinical Trial Registry, Primary Registry of WHO International Clinical Trials Registry Platform

蜀ICP备16010396号-9

Note: It is recommended to use the widescreen display resolution of Internet Explorer 8.0 or later